Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells.

Cerebral amyloid angiopathy is commonly associated with normal aging and Alzheimer's disease and it is also the principal feature of hereditary cerebral hemorrhage with amyloidosis Dutch type, a familial condition associated to a point mutation G to C at codon 693 of the amyloid beta (Abeta) precursor protein gene resulting in a Glu to Gln substitution at position 22 of the Abeta (E22Q). The patients carrying the AbetaE22Q variant usually present with lobar cerebral hemorrhages before 50 years of age. A different mutation described in several members of three Italian kindred who presented with recurrent hemorrhagic strokes late in life, between 60 and 70 years of age, also associated with extensive cerebrovascular amyloid deposition has been found at the same position 22, this time resulting in a Glu to Lys substitution (E22K). We have compared the secondary structure, aggregation, and fibrillization properties of the two Abeta40 variants and the wild type peptide. Using flow cytometry analysis after staining with propidium iodide and annexin V, we also evaluated the cytotoxic effects of the peptides on human cerebral endothelial cells in culture. Under the conditions tested, the E22Q peptide exhibited the highest content of beta-sheet conformation and the fastest aggregation/fibrillization properties. The Dutch variant also induced apoptosis of cerebral endothelial cells at a concentration of 25 micrometer, whereas the wild type Abeta and the E22K mutant had no effect. The data suggest that different amino acids at position 22 confer distinct structural properties to the peptides that appear to influence the onset and aggressiveness of the disease rather than the phenotype.

[1]  W. V. Van Nostrand,et al.  Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D. Price,et al.  Senile plaques in cortex of aged normal monkeys , 1985, Brain Research.

[3]  E. Wijsman,et al.  Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. , 1992, American journal of human genetics.

[4]  B. Ghetti,et al.  A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. , 1991, Science.

[5]  R. Martins,et al.  A mutation in codon 717 of the amyloid precursor protein gene in an Australian family with Alzheimer's disease , 1995, Neuroscience Letters.

[6]  D. Naumann,et al.  Secondary structure and temperature-induced unfolding and refolding of ribonuclease T1 in aqueous solution. A Fourier transform infrared spectroscopic study. , 1993, Journal of molecular biology.

[7]  F. Tagliavini,et al.  Parenchymal preamyloid and amyloid deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis—Dutch type , 1990, Neuroscience Letters.

[8]  R. Petersen,et al.  Transthyretin amyloidosis: A new mutation associated with dementia , 1997, Annals of neurology.

[9]  W. V. Van Nostrand,et al.  Pathologic Amyloid β‐Protein Cell Surface Fibril Assembly on Cultured Human Cerebrovascular Smooth Muscle Cells , 1998 .

[10]  J. Hardy,et al.  A novel silent variant at codon 711 and a variant at codon 708 of the APP sequence detected in Spanish Alzheimer and control cases , 1993, Neuroscience Letters.

[11]  T. Wisniewski,et al.  The prionoses and other conformational disorders. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[12]  C. Broeckhoven,et al.  The βA4 Amyloid Precursor Protein Gene and Alzheimer's Disease , 1996 .

[13]  R. Monette,et al.  Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood–brain barrier , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  C. Masters,et al.  Novel Leu723Pro amyloid precursor protein mutation increases amyloid β42(43) peptide levels and induces apoptosis , 2000, Annals of neurology.

[15]  O. Salonen,et al.  Gelsolin‐related spinal and cerebral amyloid angiopathy , 1999, Annals of neurology.

[16]  S. Tsuji,et al.  Mis-sense mutation Val→Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease , 1991, The Lancet.

[17]  G. Zubenko,et al.  Clinically-Silent Mutation in the Putative Iron-Responsive Element in Exon 17 of the β-Amyloid Precursor Protein Gene , 1992, Journal of neuropathology and experimental neurology.

[18]  C. Soto,et al.  Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. , 1996, Biochemical and biophysical research communications.

[19]  C. Cotman,et al.  Pathogenic amyloid β-protein induces apoptosis in cultured human cerebrovascular smooth muscle cells , 1999 .

[20]  W. V. Van Nostrand,et al.  Charge Alterations of E22 Enhance the Pathogenic Properties of the Amyloid β‐Protein , 2000 .

[21]  S. V. van Duinen,et al.  Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Grant,et al.  Detailed morphology of two vestibular neurones following a single intracellular injection of HRP , 1980, Neuroscience Letters.

[23]  L. Lannfelt,et al.  Amyloid precursor protein mutation at codon 713 (Ala → Val) does not cause schizophrenia: non-pathogenic variant found at codon 705 (silent) , 1995, Neuroscience Letters.

[24]  G. Bots,et al.  Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage , 1982, Journal of the Neurological Sciences.

[25]  B. Ghetti,et al.  Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Budka,et al.  Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G) , 1996, The American journal of pathology.

[27]  T Bek,et al.  A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Y. Agid,et al.  More missense in amyloid gene , 1992, Nature Genetics.

[29]  D. Clair,et al.  Mutation in codon 713 of the β amyloid precursor protein gene presenting with schizophrenia , 1992, Nature Genetics.

[30]  Agueda Rostagno,et al.  A stop-codon mutation in the BRI gene associated with familial British dementia , 1999, Nature.

[31]  J. Hardy,et al.  Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP717 Val-->Ile. , 1992, Human molecular genetics.

[32]  J. Hardy,et al.  A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43). , 1997, Human molecular genetics.

[33]  J. Ghiso,et al.  Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Hardy,et al.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene , 1991, Nature.

[35]  D. Murman,et al.  Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late‐onset Alzheimer's disease , 1994, Annals of neurology.

[36]  Brian J Cummings,et al.  Immunohistochemical evidence for apoptosis in Alzheimer's disease. , 1994, Neuroreport.

[37]  H. Fabian,et al.  Water-soluble beta-sheet models which self-assemble into fibrillar structures. , 1999 .

[38]  Brian J Cummings,et al.  The canine as an animal model of human aging and dementia , 1996, Neurobiology of Aging.

[39]  D. Campion,et al.  Unusual phenotypic alteration of β amyloid precursor protein (βAPP) maturation by a new Val-715 → Met βAPP-770 mutation responsible for probable early-onset Alzheimer’s disease , 1999 .

[40]  J. Ghiso,et al.  Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits. , 1996, The American journal of pathology.

[41]  T. Wisniewski,et al.  Biology of Aβ Amyloid in Alzheimer's Disease , 1997, Neurobiology of Disease.

[42]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[43]  I. Lieberburg,et al.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[44]  R. Fletterick,et al.  Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  T. Wisniewski,et al.  Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. , 1991, Biochemical and biophysical research communications.

[46]  A. Hofman,et al.  Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene , 1992, Nature Genetics.

[47]  A. Roses,et al.  Novel polymorphism in the A4 region of the amyloid precursor protein gene in a patient without Alzheimer's disease , 1993, Neurology.

[48]  C. Cotman,et al.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.